Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Data in Brief|September 2, 2017
Data describing IFNγ-mediated viral clearance in an adult mouse model of respiratory syncytial virus (RSV)Katherine M Eichinger, Kerry M Empey
Pediatric Pulmonology|November 9, 2017
Localization of the T-cell response to RSV infection is altered in infant miceKatherine M Eichinger, Jessica L Kosanovich, Kerry M Empey
Cancer Letters|September 22, 2023
Targeting cancer metabolic pathways for improving chemotherapy and immunotherapyZhangyi Luo, Katherine M Eichinger, Anju Zhang, et al.
Cytokine|May 31, 2017
Age predicts cytokine kinetics and innate immune cell activation following intranasal delivery of IFNγ and GM-CSF in a mouse model of RSV infectionKatherine M Eichinger, Erin Resetar, Jacob Orend, et al.
Therapeutic Advances in Vaccines and Immunotherapy|February 24, 2021
Strategies for active and passive pediatric RSV immunizationKatherine M Eichinger, Jessica L Kosanovich, Madeline Lipp, et al.
The Annals of Pharmacotherapy|November 22, 2013
Immunosuppressive aspects of analgesics and sedatives used in mechanically ventilated patients: an underappreciated risk factor for the development of ventilator-associated pneumonia in critically ill patientsMichael A Smith, Maho Hibino, Bonnie A Falcione, et al.
Respiratory Research|October 7, 2015
Alveolar macrophages support interferon gamma-mediated viral clearance in RSV-infected neonatal miceKatherine M Eichinger, Loreto Egaña, Jacob G Orend, et al.
Vaccine|August 25, 2020
Formulation of the prefusion RSV F protein with a Th1/Th2-balanced adjuvant provides complete protection without Th2-skewed immunity in RSV-experienced young miceJessica L Kosanovich, Katherine M Eichinger, Madeline A Lipp, et al.
Vaccine|November 1, 2020
Maternal immunization with adjuvanted RSV prefusion F protein effectively protects offspring from RSV challenge and alters innate and T cell immunityKatherine M Eichinger, Jessica L Kosanovich, Madeline A Lipp, et al.
Frontiers in Immunology|October 21, 2022
Prior respiratory syncytial virus infection reduces vaccine-mediated Th2-skewed immunity, but retains enhanced RSV F-specific CD8 T cell responses elicited by a Th1-skewing vaccine formulationKatherine M Eichinger, Jessica L Kosanovich, Timothy N Perkins, et al.
Pageof 2